Citation: Mri. Young et al., INCREASING INFILTRATION AND ACTIVATION OF CD8-INFILTRATING LYMPHOCYTES AFTER ELIMINATING IMMUNE SUPPRESSIVE GRANULOCYTE-MACROPHAGE PROGENITOR CELLS WITH LOW-DOSES OF INTERFERON GAMMA-PLUS TUMOR-NECROSIS-FACTOR-ALPHA( TUMOR), Cancer immunology and immunotherapy, 38(1), 1994, pp. 9-15
Citation: T. Asano et al., LIPOSOME-ENCAPSULATED MURAMYL TRIPEPTIDE UP-REGULATES MONOCYTE CHEMOTACTIC AND ACTIVATING FACTOR GENE-EXPRESSION IN HUMAN MONOCYTES AT THE TRANSCRIPTIONAL AND POSTTRANSCRIPTIONAL LEVELS, Cancer immunology and immunotherapy, 38(1), 1994, pp. 16-22
Citation: M. Awwad et al., MODIFICATION OF MONOCLONAL-ANTIBODY CARBOHYDRATES BY OXIDATION, CONJUGATION, OR DEOXYMANNOJIRIMYCIN DOES NOT INTERFERE WITH ANTIBODY EFFECTOR FUNCTIONS, Cancer immunology and immunotherapy, 38(1), 1994, pp. 23-30
Authors:
KERREBIJN JD
BALM AJM
KNEGT PP
MEEUWIS CA
DREXHAGE HA
Citation: Jd. Kerrebijn et al., MACROPHAGE AND DENDRITIC CELL INFILTRATION IN HEAD AND NECK SQUAMOUS-CELL CARCINOMA - AN IMMUNOHISTOCHEMICAL STUDY, Cancer immunology and immunotherapy, 38(1), 1994, pp. 31-37
Authors:
BARNA BP
THOMASSEN MJ
MAIER M
MEDENDORP SV
TUBBS RR
CHIANG T
PING Z
YENLIEBERMAN B
SINGHBURGESS S
DEODHAR SD
Citation: Bp. Barna et al., COMBINATION THERAPY WITH A SYNTHETIC PEPTIDE OF C-REACTIVE PROTEIN AND INTERLEUKIN-2 - AUGMENTED SURVIVAL AND ERADICATION OF PULMONARY METASTASES, Cancer immunology and immunotherapy, 38(1), 1994, pp. 38-42
Citation: Ka. Smans et al., REQUIREMENT OF MONOCYTES AND T-HELPER CELLS DURING DEVELOPMENT OF TUMOR-CELL CYTOTOXICITY IN TARGETED T-CELLS, Cancer immunology and immunotherapy, 38(1), 1994, pp. 43-52
Citation: Raj. Janssen et al., POOR INDUCTION OF INTERLEUKIN-2 RECEPTOR EXPRESSION ON CD8BRIGHT-BLOOD CELL-CULTURES WITH CD3 MAB - IMPLICATIONS FOR IMMUNOTHERAPY WITH CD3MAB( CELLS IN WHOLE), Cancer immunology and immunotherapy, 38(1), 1994, pp. 53-60
Citation: Pjk. Kuppen et al., SOLUBLE FACTORS PRODUCED BY MACROPHAGES MONOCYTES INHIBIT LYMPHOKINE-ACTIVATED KILLER ACTIVITY IN RAT SPLENOCYTE CULTURES, Cancer immunology and immunotherapy, 38(1), 1994, pp. 61-67
Authors:
MATHEW A
CHENG HM
SAM CK
JOAB I
PRASAD U
COCHET C
Citation: A. Mathew et al., A HIGH-INCIDENCE OF SERUM IGG ANTIBODIES TO THE EPSTEIN-BARR-VIRUS REPLICATION ACTIVATOR PROTEIN IN NASOPHARYNGEAL CARCINOMA, Cancer immunology and immunotherapy, 38(1), 1994, pp. 68-70
Authors:
VEGH Z
WANG P
VANKY F
HISING C
SJOWALL K
LARSSON B
KLEIN E
Citation: Z. Vegh et al., CYTOTOXIC SUSCEPTIBILITY AND DEFECTIVE MHC CLASS-I EXPRESSION DO NOT CORRELATE WITH MUTATION OF P53 IN HUMAN CARCINOMAS, Cancer immunology and immunotherapy, 38(1), 1994, pp. 71-73
Citation: Un. Verma et A. Mazumder, IMMUNE RECONSTITUTION FOLLOWING BONE-MARROW TRANSPLANTATION, Cancer immunology and immunotherapy, 37(6), 1993, pp. 351-360
Citation: Rl. Darley et Ag. Morris, SEQUENTIAL-CHANGES IN MHC ANTIGEN EXPRESSION INDUCED BY THE V-KI-RAS ONCOGENE, Cancer immunology and immunotherapy, 37(6), 1993, pp. 361-366
Authors:
EISENTHAL A
SKORNICK Y
RON I
ZAKUTH V
CHAITCHIK S
Citation: A. Eisenthal et al., PHENOTYPIC AND FUNCTIONAL PROFILE OF PERIPHERAL-BLOOD MONONUCLEAR-CELLS ISOLATED FROM MELANOMA PATIENTS UNDERGOING COMBINED IMMUNOTHERAPY AND CHEMOTHERAPY, Cancer immunology and immunotherapy, 37(6), 1993, pp. 367-372
Citation: Jj. Chen et H. Kohler, TUMOR IDIOTYPE VACCINES .8. ANALYSIS OF PROTECTIVE IDIOTYPE IN SERA AND HYBRIDOMAS DERIVED FROM TUMOR-BEARING MICE WITH LONG-TERM SURVIVAL, Cancer immunology and immunotherapy, 37(6), 1993, pp. 373-377
Authors:
HOON DSB
HAYASHI Y
MORISAKI T
FOSHAG LJ
MORTON DL
Citation: Dsb. Hoon et al., INTERLEUKIN-4 PLUS TUMOR-NECROSIS-FACTOR-ALPHA AUGMENTS THE ANTIGENICITY OF MELANOMA-CELLS, Cancer immunology and immunotherapy, 37(6), 1993, pp. 378-384
Citation: K. Ryoyama et al., INHIBITION OF MACROPHAGE NITRIC-OXIDE PRODUCTION BY ARACHIDONATE-CASCADE INHIBITORS, Cancer immunology and immunotherapy, 37(6), 1993, pp. 385-391
Authors:
UMEZU Y
AUGUSTUS LB
SEITO D
HAYAKAWA K
ROSS MI
ETON O
SWANSON DA
ITOH K
Citation: Y. Umezu et al., INCREASE IN THE ABILITY OF HUMAN CANCER-CELLS TO INDUCE CYTOTOXIC T-LYMPHOCYTES BY ULTRAVIOLET-IRRADIATION, Cancer immunology and immunotherapy, 37(6), 1993, pp. 392-399
Authors:
KROESEN BJ
TERHAAR A
SPAKMAN H
WILLEMSE P
SLEIJFER DT
DEVRIES EGE
MULDER NH
BERENDSEN HH
LIMBURG PC
THE TH
DELEIJ L
Citation: Bj. Kroesen et al., LOCAL ANTITUMOR TREATMENT IN CARCINOMA PATIENTS WITH BISPECIFIC-MONOCLONAL-ANTIBODY-REDIRECTED T-CELLS, Cancer immunology and immunotherapy, 37(6), 1993, pp. 400-407
Authors:
ASANO T
FUJIMAKI W
MCWATTERS A
AN TH
MATSUSHIMA K
KLEINERMAN ES
Citation: T. Asano et al., EFFECT OF ADRIAMYCIN ON LIPOSOMAL MURAMYL TRIPEPTIDES ABILITY TO UP-REGULATE MONOCYTE CYTOKINE EXPRESSION, Cancer immunology and immunotherapy, 37(6), 1993, pp. 408-411
Authors:
KOBAYASHI H
SAKAHARA H
HOSONO M
SHIRATO M
KONISHI J
TAKAHASHI JA
ODA Y
KIKUCHI H
ENDO K
KOZAI Y
HATANAKA M
Citation: H. Kobayashi et al., SCINTIGRAPHIC DETECTION OF XENOGRAFTED TUMORS PRODUCING HUMAN BASIC FIBROBLAST GROWTH-FACTOR, Cancer immunology and immunotherapy, 37(5), 1993, pp. 281-285
Authors:
SHILONI E
KARP SE
CUSTER MC
SHILYANSKY J
RESTIFO NP
ROSENBERG SA
MULE JJ
Citation: E. Shiloni et al., RETROVIRAL TRANSDUCTION OF INTERFERON-GAMMA CDNA INTO A NONIMMUNOGENIC MURINEFIBROSARCOMA - GENERATION OF T-CELLS IN DRAINING LYMPH-NODES CAPABLE OF TREATING ESTABLISHED PARENTAL METASTATIC TUMOR, Cancer immunology and immunotherapy, 37(5), 1993, pp. 286-292
Authors:
STEIN R
BELISLE E
HANSEN HJ
GOLDENBERG DM
Citation: R. Stein et al., EPITOPE SPECIFICITY OF THE ANTI-(B-CELL LYMPHOMA) MONOCLONAL-ANTIBODY, LL2, Cancer immunology and immunotherapy, 37(5), 1993, pp. 293-298
Authors:
BLACK PL
PHILLIPS H
TRIBBLE HR
PENNINGTON R
SCHNEIDER M
TALMADGE JE
Citation: Pl. Black et al., ANTITUMOR RESPONSE TO RECOMBINANT MURINE INTERFERON-GAMMA CORRELATES WITH ENHANCED IMMUNE FUNCTION OF ORGAN-ASSOCIATED, BUT NOT RECIRCULATING CYTOLYTIC T-LYMPHOCYTES AND MACROPHAGES, Cancer immunology and immunotherapy, 37(5), 1993, pp. 299-306
Authors:
LINDEMANN A
BROSSART P
HOFFKEN K
FLASSHOVE M
VOLIOTIS D
DIEHL V
HECKER G
WAGNER H
MERTELSMANN R
Citation: A. Lindemann et al., IMMUNOMODULATORY EFFECTS OF ULTRA-LOW-DOSE INTERLEUKIN-2 IN CANCER-PATIENTS - A PHASE-IB STUDY, Cancer immunology and immunotherapy, 37(5), 1993, pp. 307-315
Citation: N. Morioka et al., A PROTEIN-FRACTION FROM AGED GARLIC EXTRACT ENHANCES CYTOTOXICITY ANDPROLIFERATION OF HUMAN-LYMPHOCYTES MEDIATED BY INTERLEUKIN-2 AND CONCANAVALIN-A, Cancer immunology and immunotherapy, 37(5), 1993, pp. 316-322